Phase I Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Resistant Solid Malignancies.
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2014
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Temsirolimus (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2012 Actual patients number is 28 as reported by ClinicalTrials.gov.
- 22 Jun 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.